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Since the formulation of the hypothesis, by Mary Lyon
(1961), of X-chromosome inactivation in somatic cells
of female mammals, studies of the biology and the con-
sequences of this phenomenon have contributed to our
understanding of many areas of genetics and develop-
ment. Montiero et al. (1998 [in this issue]) have now
extended the application of X-inactivation studies to a
careful and quantitative dissection of the timing of MZ
twinning, demonstrating that dichorionic MZ (DC-MZ)
twinning, unlike monochorionic MZ (MC-MZ) twin-
ning, occurs prior to the time of X inactivation in the
embryo.
Recent discoveries have illuminated many details of
the X-inactivation story, but the precise molecular events
in the initiation and maintenance of X inactivation are
not yet fully known. We now appreciate that expression
levels of the great majority of X-encoded genes are equal-
ized between XY males and XX females by permanent
silencing of one or the other X chromosome in the cells
of female somatic tissues. Normal X inactivation occurs
in the early female embryo as a stochastic event—that
is, a choice made independently in each cell, with an
equal probability of the maternally derived versus pa-
ternally derived X chromosome becoming inactive. The
X inactivation of individual embryonic cells is consid-
ered most likely to be initiated from the X-inactivation
center by XIST (X inactivation–specific transcript),
which, unlike most genes, does not encode a protein and,
paradoxically, is expressed only from the inactive X in
postinactivation somatic cells (Brown et al. 1992). At
the time of X inactivation, XIST RNA functions in cis
to spread an inactivating signal up and down the chro-
mosome on which it resides (Willard 1995). X inacti-
vation is then maintained throughout subsequent cel-
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lular proliferation and differentiation, by continued
XIST expression and by methylation of DNA cytosine
residues.
Because of X inactivation, tissues of females are nor-
mally a mosaic of two cell populations, each expressing
gene alleles from either their paternal or their maternal
X chromosome. Deviations from random X inactivation
have been used to demonstrate clonal proliferations of
malignant cells, positive or negative selection in carriers
of adrenoleukodystrophy or X-linked immune disorders,
and even primary disturbances of the X-inactivation pro-
cess itself (reviewed in Belmont 1996; Puck and Willard
1998).
Measuring the distribution of X-inactivation skewing
also has been exploited to estimate the number of em-
bryonic progenitor cells giving rise to a particular tissue.
If we assume that the maternal or paternal X chromo-
some is inactivated at random, analogous to tossing a
coin and getting heads or tails, X-inactivation patterns
would be expected to follow a binomial distribution
from which the number of original inactivation events
can be calculated. X-inactivation ratios for derivation of
the best-fit binomial curve can be determined, provided
that there are ways to (i) distinguish the two X chro-
mosomes and (ii) indicate which X chromosome is ac-
tive. This initially was done at the protein level, with
samples from women whose X chromosomes were het-
erozygous for different glucose-6-phosphate dehydrog-
enase alleles (Fialkow 1973). Estimates suggested that
X inactivation occurs when there are ∼20 embryonic
cells. Subsequently, fusion of human lymphocytes with
rodent cells lacking the X-linked enzyme hypoxanthine
phosphoribosyltransferase was used to select active hu-
man X chromosomes in hybrid cell lines, where they
could be identified by polymorphic DNA markers (Puck
et al. 1992). Quantitations from enumeration of active-
X frequencies in somatic-cell hybrids yielded estimates
consistent with the previous data, with ∼10 cells giving
rise to the population that forms bone-marrow stem
cells. The proximity, in the X-linked androgen receptor
(AR) gene, of a highly informative polymorphic
(CAG)17–26 repeat and methylation-sensitive restriction
sites that are methylated on inactive X chromosomes
recently has streamlined determination of X-inactivation
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ratios (Allen et al. 1994). Parallel DNA samples, one
predigested with HpaII and the other not, are subjected
to PCR with primers flanking both HpaII sites and the
triplet repeat; only the methylated template strands from
inactive X chromosomes remain intact to be amplified,
separated by electrophoresis, and quantitated.
Monteiro et al. (1998) have used the latter method to
evaluate X-chromosome inactivation in the context of
another mysterious phenomenon of very early human
gestation—the formation of MZ twins: X-inactivation
patterns were determined in samples of both buccal-mu-
cosal and blood DNA from a large series of 33 MZ-
twin females and 21 singleton control females. The pla-
cental and fetal membranes of the twins were analyzed;
20 were MC-MZ, known to be the more common type
and believed, on the basis of placental anatomy, to split
later than DC-MZ twins (Derom et al. 1995). To validate
their X chromosome–inactivation analysis, Monteiro et
al. were careful first to establish that the AR methylation
assay in their hands was quantitative and reproducible
to !5% difference (Monteiro et al. 1998). Next, they
determined norms for skewing of X inactivation in fe-
male singleton control blood and mucosal-cell DNA; as
measured by AR methylation, there were overall similar
degrees of skewing in the two tissues, with the single
exception of highly skewed blood DNA in one subject
(specific variation between tissues for each individual
otherwise were not given, which is unfortunate in that
such data are scarce in the published literature).
Monteiro et al.’s estimate of the number of cells at
the time of X inactivation, 5–16, is in the range of pre-
vious reports, cited above, which used different methods.
Although the overall mean and range of X-inactivation
skewing of the twins was not different from that seen
in the control singletons, there was a significant differ-
ence in X inactivation between co-twins. Not only was
the blood DNA of MC-MZ twins matched in X-inac-
tivation skewing (previously reported and possibly due
to known mixing of blood in mingled placental circu-
lations for this type of twin [Trejo et al. 1994]), but MC-
MZ ectodermally derived buccal-cell DNA also showed
highly similar X-inactivation skewing, !6% difference
between one twin to the other. In contrast, the DC-MZ
twins had significantly greater mean differences in buc-
cal-cell and blood DNA skewing—14% and 23%, re-
spectively. These results clearly indicate that DC-MZ
twinning occurs before or at the time of X inactivation,
whereas MC-MZ twinning occurs some three or so rep-
lication rounds later, after X-inactivation patterns have
been established and the embryonic inner-cell mass con-
tains on the order of 128–256 cells.
How, then, are we to interpret reports of MZ twins
concordant or discordant for expression of genetic phe-
notypes—and, in particular, female MZ twins one of
whom suffers from an X-linked recessive phenotype,
such as Duchenne muscular dystrophy (Lupski et al.
1991)? Repeatedly, the female twin expressing such a
phenotype has been shown to have extreme skewing of
X inactivation; however, her status as monochorionic or
dichorionic is generally not known. The report by Mon-
teiro et al. emphasizes that, although such extreme skew-
ing is not common in MZ twins, since it was not seen
in their study cohort, the timing of twinning must be
considered as an additional important variable in twin
studies.
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